Back to Trades
Lazar David E.
Chief Executive OfficerDirector10% OwnerCIK 0001932843
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 17
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 7
- Active
- 2025–2026
Lazar David E., Chief Executive Officer, Director, 10% Owner, accounts for 17 disclosed filings worth $6.6B, spread across 7 companies, active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $83.4K in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
17 loaded
| Aug 7 | QUCY Quantum Cyber N.V. | Lazar David E. | Chief Executive Officer, Director, 10% Owner | Conversion | $6.6B |
| May 1 | ATER Aterian, Inc. | Lazar David E. | Director | Award | $0 |
| May 1 | ATER Aterian, Inc. | Lazar David E. | Director | Other | $0 |
| Apr 28 | MYNZ Quantum Cyber N.V. | Lazar David E. | Chief Executive Officer, Director, 10% Owner | Award | $0 |
| Apr 2 | SOWG Sow Good Inc. | Lazar David E. | Director | Grant | $819.7K |
| Mar 3 | MYNZ MAINZ BIOMED N.V. | Lazar David E. | Director | Award | $0 |
| Mar 3 | MYNZ MAINZ BIOMED N.V. | Lazar David E. | Director | Other | $0 |
| Jan 29 | NBY NovaBay Pharmaceuticals, Inc. | Lazar David E. | 10% Owner | Grant | $0 |
| Jan 5 | SOWG Sow Good Inc. | Lazar David E. | Chief Executive Officer, Director | Award | $214.2K |
| Jan 5 | SOWG Sow Good Inc. | Lazar David E. | Director | Other | $0 |
| Dec 23 | INDP Indaptus Therapeutics, Inc. | Lazar David E. | Co-Chief Executive Officer | Other | $0 |
| Dec 22 | KALA KALA BIO, Inc. | Lazar David E. | Chief Executive Officer, Director | Other | $374.9K |
| Dec 2 | KALA KALA BIO, Inc. | Lazar David E. | Chief Executive Officer, Director | Other | $0 |
| Nov 26 | KALA KALA BIO, Inc. | Lazar David E. | Chief Executive Officer, Director | Award | $0 |
| Nov 26 | KALA KALA BIO, Inc. | Lazar David E. | Chief Executive Officer, Director | Other | $0 |
| Oct 17 | NBY NovaBay Pharmaceuticals, Inc. | Lazar David E. | 10% Owner | Other | $0 |
| Aug 4 | CYCC Cyclacel Pharmaceuticals, Inc. | Lazar David E. | 10% Owner | Sell | $83.4K |
17 filings